Key Takeaways on the Treatment of Patients With Relapsed/Refractory MM

Opinion
Video

The expert panel closes the discussion with key takeaways on the relapsed/refractory multiple myeloma treatment landscape.

Recent Videos
The dual high-affinity binding observed with ISB 2001 may avoid resistance mechanisms reported with other BCMA-targeted therapies.
Related Content